Allergan

Latest stories

13h
BBC News
Valeant's outgoing boss 'regrets' raising drug pricespartner to Mr Pearson. After all that has happened - the threat of a default,
Valeant's outgoing boss 'regrets' raising drug prices
BBC News / Posted 13 hours ago
partner to Mr Pearson. After all that has happened - the threat of a default, several failed attempts to buy Botox-maker Allergan, a scandal involving "phantom" pharmacies, federal investigations, and an 80% drop in the company's share price in... Read more
18h
Morningstar
Allergan Still UndervaluedWe think Allergan’s diverse portfolio of defensible products, broad pipeline, a
Allergan Still Undervalued
Morningstar / Posted 18 hours ago
We think Allergan’s diverse portfolio of defensible products, broad pipeline, and future potential acquisitions will sustain healthy earnings growth. The acquisitions of Warner Chilcott and Forest Labs greatly enhanced the company’s branded drug... Read more
1d
Business Standard India
Aurobindo, Intas seek to boost Europe business with Teva bidits products in Britain and Ireland on the block as a part of anti-trust requir
Aurobindo, Intas seek to boost Europe business with Teva bid
Business Standard India / Posted yesterday
its products in Britain and Ireland on the block as a part of anti-trust requirement following acquisition of drug maker Allergan last year. A report in The Economic Times said Aurobindo and Intas had submitted binding offers for Allergan's... Read more
1d
Kenosha News
Conservatives reap most political donationsUnion of Bricklayers & Allied CraftWorkers PAC: 36 — Allstate Insurance Co. PA
Conservatives reap most political donations
Kenosha News / Posted yesterday
Union of Bricklayers & Allied CraftWorkers PAC: 36 — Allstate Insurance Co. PAC: 27 — Astellas US LLC PAC: 24 — Allergan PAC: 23 — Engineers Political Education Committee: 20 — Laborers International Union of North America PAC: 18 —... Read more
1d
The Economic Times
Aurobindo, Intas in race for $1 billion buyout of Teva UK, submit binding offerssaid multiple sources with knowledge of the matter. Teva is selling assets as
Aurobindo, Intas in race for $1 billion buyout of Teva UK, submit binding offers
The Economic Times / Posted yesterday
said multiple sources with knowledge of the matter. Teva is selling assets as part of its $40.5-billion acquisition of Allergan Plc's generics business that was announced last year. In various deals in June, Teva sold around 80 products in the... Read more
3d
Stamford Advocate
One of the key men behind Bill Ackman's bet on Valeant is leavingan investment analyst, Rubin, 32, contributed to positions including Valeant Ph
One of the key men behind Bill Ackman's bet on Valeant is leaving
Stamford Advocate / Posted 3 days ago
an investment analyst, Rubin, 32, contributed to positions including Valeant Pharmaceuticals International, Zoetis, Allergan and Family Dollar. "I think extremely highly of Jordan," Ackman told Business Insider. "He's a very talented, hard... Read more
4 related stories
3d
Connecticut Post
One of the key men behind Bill Ackman's bet on Valeant is leavingan investment analyst, Rubin, 32, contributed to positions including Valeant Ph
One of the key men behind Bill Ackman's bet on Valeant is leaving
Connecticut Post / Posted 3 days ago
an investment analyst, Rubin, 32, contributed to positions including Valeant Pharmaceuticals International, Zoetis, Allergan and Family Dollar. "I think extremely highly of Jordan," Ackman told Business Insider. "He's a very talented, hard... Read more
4 related stories
3d
Business Insider
One of the key men behind Bill Ackman's bet on Valeant is leavingan investment analyst, Rubin, 32, contributed to positions including Valeant Ph
One of the key men behind Bill Ackman's bet on Valeant is leaving
Business Insider / Posted 3 days ago
an investment analyst, Rubin, 32, contributed to positions including Valeant Pharmaceuticals International, Zoetis, Allergan and Family Dollar. "I think extremely highly of Jordan," Ackman told Business Insider. "He's a very talented, hard... Read more
4 related stories
3d
USA Today
Drug money: Pharma CEOs are paid 71% moreJeffrey Leiden, $28,099,826 Merck, MRK, Kenneth Frazier, $24,208,083 Johnson
Drug money: Pharma CEOs are paid 71% more
USA Today / Posted 3 days ago
Jeffrey Leiden, $28,099,826 Merck, MRK, Kenneth Frazier, $24,208,083 Johnson & Johnson, JNJ, Alex Gorsky, $23,795,866 Allergan, AGN, Brenton Saunders, $21,565,549 AbbVie, ABBV, Richard Gonzalez, $20,810,103 Mylan, MYL, Heather Bresch,... Read more
2 related stories
3d
CNBC
Bill Ackman: 'We made one very big mistake' with Valeant and lost big timerules with Valeant, initially striking up a partnership with the Canadian drugm
Bill Ackman: 'We made one very big mistake' with Valeant and lost big time
CNBC / Posted 3 days ago
rules with Valeant, initially striking up a partnership with the Canadian drugmaker in 2014 to try to buy Botox-maker Allergan. The unique arrangement raised questions at the time about a conflict of interest, an assertion Ackman had... Read more
4 related stories
4d
Sky News Australia
Mayne Pharma flags future growthwith earnings coming online from the generic drugs it agreed in June to buy fro
Mayne Pharma flags future growth
Sky News Australia / Posted 4 days ago
with earnings coming online from the generic drugs it agreed in June to buy from Teva Pharmaceutical Industries and Allergan for $US652 million. 'The company has significant growth opportunities across multiple channels and all US business... Read more
2 related stories
4d
TheBull
Mayne Pharma flags 'very positive' yearwith earnings coming online from the generic drugs it agreed in June to buy fro
Mayne Pharma flags 'very positive' year
TheBull / Posted 4 days ago
with earnings coming online from the generic drugs it agreed in June to buy from Teva Pharmaceutical Industries and Allergan for $US652 million. "The company has significant growth opportunities across multiple channels and all US business... Read more
2 related stories
4d
Newser
Markets End the Day Lowerreports. Biotechnology companies continued to fall Thursday as pressure mounts
Markets End the Day Lower
Newser / Posted 4 days ago
reports. Biotechnology companies continued to fall Thursday as pressure mounts on them over their drug pricing practices. Allergan fell 3% and Celgene lost 2%. Mylan, which has been under fire for steep price increases in its EpiPen product, lost... Read more
4d
The Mercury News
Pfizer acquires AstraZeneca antibioticsits shopping spree with its fourth acquisition since the April collapse of its
Pfizer acquires AstraZeneca antibiotics
The Mercury News / Posted 4 days ago
its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in lower-tax Ireland. In its second deal this week, New... Read more
30 related stories
4d
The Economic Times
Former Wipro top executive Sangita Singh may join Infosyson outsourcing budgets. Indian IT companies have had to face the brunt of the c
Former Wipro top executive Sangita Singh may join Infosys
The Economic Times / Posted 4 days ago
on outsourcing budgets. Indian IT companies have had to face the brunt of the collapse in the proposed merger of Pfizer and Allergan. This shut the tap on large IT outsourcing opportunities. Cognizant, which has a large exposure to the healthcare... Read more
4d
The Economic Times
Former Wipro top executive Sangita Singh may join Infosyson outsourcing budgets. Indian IT companies have had to face the brunt of the c
Former Wipro top executive Sangita Singh may join Infosys
The Economic Times / Posted 4 days ago
on outsourcing budgets. Indian IT companies have had to face the brunt of the collapse in the proposed merger of Pfizer and Allergan. This shut the tap on large IT outsourcing opportunities. Cognizant, which has a large exposure to the healthcare... Read more
5d
The Columbian
Stocks lower, health-care companies declinedrug pricing practices could spread to other drugmakers. Vertex Pharmaceuticals
Stocks lower, health-care companies decline
The Columbian / Posted 5 days ago
drug pricing practices could spread to other drugmakers. Vertex Pharmaceuticals fell $4.28, or 4.2 percent, to $96.71 and Allergan fell $9.94, or 3.9 percent, to $243.77. Stocks remain stuck in a narrow range, as they have over the last two... Read more
2 related stories
5d
Boston Globe
Pfizer to buy antibiotics from AstraZeneca for $725 millionand portfolio of marketed drugs after two failed attempts at a major acquisitio
Pfizer to buy antibiotics from AstraZeneca for $725 million
Boston Globe / Posted 5 days ago
and portfolio of marketed drugs after two failed attempts at a major acquisition, first with AstraZeneca in 2014, then with Allergan Plc this year. The US drugmaker this week agreed to buy Medivation Inc., maker of the Xtandi prostate cancer drug,... Read more
30 related stories
5d
San Antonio Express-News
Pfizer nets smaller dealsits shopping spree with its fourth acquisition since the April collapse of its
Pfizer nets smaller deals
San Antonio Express-News / Posted 5 days ago
its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in lower-tax Ireland. In its second deal this week, New... Read more
30 related stories
5d
San Antonio Express-News
Business News Roundup, Aug. 25its shopping spree with its fourth acquisition since the April collapse of its
Business News Roundup, Aug. 25
San Antonio Express-News / Posted 5 days ago
its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan’s base in lower-tax Ireland. In its second deal this week,... Read more
30 related stories
5d
The Middletown Press
Stocks end lower as health-care companies declinedrug pricing practices could spread to other drugmakers. Vertex Pharmaceuticals
Stocks end lower as health-care companies decline
The Middletown Press / Posted 5 days ago
drug pricing practices could spread to other drugmakers. Vertex Pharmaceuticals fell $4.28, or 4.2 percent, to $96.71 and Allergan fell $9.94, or 3.9 percent, to $243.77. Metals and mining stocks also took hefty losses following disappointing... Read more
2 related stories
5d
Belfast Telegraph
Stocks end lower as health-care companies declinepricing practices could spread to other drugmakers. Vertex Pharmaceuticals fell
Stocks end lower as health-care companies decline
Belfast Telegraph / Posted 5 days ago
pricing practices could spread to other drugmakers. Vertex Pharmaceuticals fell 4.28 dollars, or 4.2%, to 96.71 dollars and Allergan fell 9.94 dollars, or 3.9%, to 243.77 dollars. Metals and mining stocks also took hefty losses following... Read more
2 related stories
5d
Business Wire
Teva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE® 40 mgCopaxone® (which faces competition from orally-administered alternatives and a
Teva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE® 40 mg
Business Wire / Posted 5 days ago
Copaxone® (which faces competition from orally-administered alternatives and a generic version); our ability to integrate Allergan plc’s worldwide generic pharmaceuticals business (“Actavis Generics”) and to realize the anticipated benefits of the... Read more
5d
Chattanooga Times Free Press
Pfizer on buying spree with AstraZeneca antibiotics dealits shopping spree with its fourth acquisition since the April collapse of its
Pfizer on buying spree with AstraZeneca antibiotics deal
Chattanooga Times Free Press / Posted 5 days ago
its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in lower-tax Ireland. In its second deal this week, New... Read more
30 related stories
5d
Daily Record
Allergan, United Way, Riker Danzig in Morris County business newsAllergan consolidating to 5 Giralda Farms MORRISTOWN: Riker Danzig Scherer Hyl
Allergan, United Way, Riker Danzig in Morris County business news
Daily Record / Posted 5 days ago
Allergan consolidating to 5 Giralda Farms MORRISTOWN: Riker Danzig Scherer Hyland & Perretti’s Real Estate Group represented a Lincoln Equities partnership in the lease and repositioning of 5 Giralda Farms for new tenant Allergan Sales. Allergan... Read more
5d
FOX Business
Dear Pfizer, Stop Overpaying for Acquisitions!coming out ahead following its Anacor deal until perhaps 2024 or 2025. There w
Dear Pfizer, Stop Overpaying for Acquisitions!
FOX Business / Posted 5 days ago
coming out ahead following its Anacor deal until perhaps 2024 or 2025. There was also Pfizer's attempted acquisition of Allergan(NYSE: AGN), which eventually turned out to be nothing more than a disguised tax inversion deal. The deal would have... Read more
117 related stories
5d
FOX Business
Dear Pfizer, Stop Overpaying for Acquisitions!coming out ahead following its Anacor deal until perhaps 2024 or 2025. There w
Dear Pfizer, Stop Overpaying for Acquisitions!
FOX Business / Posted 5 days ago
coming out ahead following its Anacor deal until perhaps 2024 or 2025. There was also Pfizer's attempted acquisition of Allergan(NYSE: AGN), which eventually turned out to be nothing more than a disguised tax inversion deal. The deal would have... Read more
117 related stories
5d
Daily Record
Pfizer on buying spree with AstraZeneca antibiotics dealits shopping spree with its fourth acquisition since the April collapse of its
Pfizer on buying spree with AstraZeneca antibiotics deal
Daily Record / Posted 5 days ago
its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan’s base in lower-tax Ireland. In its second deal this week, New... Read more
30 related stories
5d
Philly.com
Pfizer on buying spree with AstraZeneca antibiotics dealits shopping spree with its fourth acquisition since the April collapse of its
Pfizer on buying spree with AstraZeneca antibiotics deal
Philly.com / Posted 5 days ago
its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in lower-tax Ireland. In its second deal this week, New... Read more
30 related stories
5d
The Register NorthJersey.com
Pfizer to buy antibiotics from AstraZeneca for $725 millionand portfolio of marketed drugs after two failed attempts at a major acquisitio
Pfizer to buy antibiotics from AstraZeneca for $725 million
The Register NorthJersey.com / Posted 5 days ago
and portfolio of marketed drugs after two failed attempts at a major acquisition, first with AstraZeneca in 2014, then with Allergan this year. The U.S. drugmaker this week agreed to buy Medivation Inc., maker of the Xtandi prostate cancer drug, in... Read more
30 related stories
5d
USA Today
Pfizer acquires anti-invectives from AstraZenecahunting through growth by acquisition — and particularly Pfizer following the c
Pfizer acquires anti-invectives from AstraZeneca
USA Today / Posted 5 days ago
hunting through growth by acquisition — and particularly Pfizer following the collapse of its tax inversion merger with Allergan, which the U.S. Treasury Department cratered. The AstraZeneca deal gives Pfizer the rights to several drugs,... Read more
5d
Market Watch
Pfizer buys antibiotics assets from AstraZenecadrugs in clinical trials. It will give Pfizer the right to sell those drugs in
Pfizer buys antibiotics assets from AstraZeneca
Market Watch / Posted 5 days ago
drugs in clinical trials. It will give Pfizer the right to sell those drugs in most markets outside the U.S. and Canada. Allergan PLC holds the North American rights to four of the drugs. For the fifth drug, Merem, Pfizer will get the North... Read more
30 related stories
5d
Channel NewsAsia
AstraZeneca sells part of antibiotics unit to Pfizerbid from Pfizer after a lengthy unsolicited courtship. And in April 2016, Pfiz
AstraZeneca sells part of antibiotics unit to Pfizer
Channel NewsAsia / Posted 5 days ago
bid from Pfizer after a lengthy unsolicited courtship. And in April 2016, Pfizer axed a proposed $160-billion merger with Allergan after the US Treasury set new rules designed to block cross-border deals that are structured to avoi... Read more
117 related stories
5d
Market Watch
AstraZeneca sells antibiotics assets to Pfizerdrugs in clinical trials. It will give Pfizer the right to sell those drugs in
AstraZeneca sells antibiotics assets to Pfizer
Market Watch / Posted 5 days ago
drugs in clinical trials. It will give Pfizer the right to sell those drugs in most markets outside the U.S. and Canada. Allergan PLC holds the North American rights to four of the drugs. For the fifth drug, Merem, Pfizer will get the North... Read more
30 related stories
6d
FOX Business
3 Stocks Billionaires Are Buyingsuccess includes his efforts to convinceeBay to spin off Paypal Holdings. In Q
3 Stocks Billionaires Are Buying
FOX Business / Posted 6 days ago
success includes his efforts to convinceeBay to spin off Paypal Holdings. In Q2, Icahn set his sights on the drugmaker Allergan(NYSE: AGN).Icahn acquired3.4 million shares of the company worth $862 millionduring the quarter. Icahn reported... Read more
6d
FOX Business
3 Stocks Billionaires Are Buyingsuccess includes his efforts to convinceeBay to spin off Paypal Holdings. In Q
3 Stocks Billionaires Are Buying
FOX Business / Posted 6 days ago
success includes his efforts to convinceeBay to spin off Paypal Holdings. In Q2, Icahn set his sights on the drugmaker Allergan(NYSE: AGN).Icahn acquired3.4 million shares of the company worth $862 millionduring the quarter. Icahn reported... Read more
6d
Profit Confidential
Pfizer Inc.: Medivation Acquisition Could Send Pfizer Stock Soaringgalactic sum. But, Pfizer has been on the hunt for a major acquisition for at l
Pfizer Inc.: Medivation Acquisition Could Send Pfizer Stock Soaring
Profit Confidential / Posted 6 days ago
galactic sum. But, Pfizer has been on the hunt for a major acquisition for at least a year. Last year, Pfizer almost bought Allergan plc. (NYSE:AGN), a major global producer of cosmetic Botox, among other things. This would have created a pharma... Read more
117 related stories
6d
FOX News
Pfizer boosts cancer drug roster with $14B Medivation dealsaid its earnings would increase immediately after buying Medivation. The deal
Pfizer boosts cancer drug roster with $14B Medivation deal
FOX News / Posted 6 days ago
said its earnings would increase immediately after buying Medivation. The deal comes four months after it and Ireland-based Allergan Plc scrapped their $160-billion merger. Pfizer has since bought Anacor Pharmaceuticals Inc in a $5.2 billion deal to... Read more
117 related stories
6d
Arkansas Democrat-Gazette
Pfizer's $14B nets cancer-drug firmfourth quarter. The Pfizer-Medivation deal is much smaller than Pfizer's propo
Pfizer's $14B nets cancer-drug firm
Arkansas Democrat-Gazette / Posted 6 days ago
fourth quarter. The Pfizer-Medivation deal is much smaller than Pfizer's proposed, $160 billion combination with Ireland's Allergan, a plan the drugmakers scrapped after the Treasury Department issued new rules this spring aimed specially at... Read more
117 related stories
6d
Scotsman
Pfizer in $14 billion swoop for cancer drug makerbreast cancer treatment talazoparib and a lymphoma drug. The takeover comes fo
Pfizer in $14 billion swoop for cancer drug maker
Scotsman / Posted 6 days ago
breast cancer treatment talazoparib and a lymphoma drug. The takeover comes four months after Pfizer and Ireland-based Allergan scrapped their proposed $160bn merger that had been based on a move to reduce taxes. Pfizer has since bought Anacor... Read more
117 related stories
7d
Boston Globe
Pfizer to buy cancer drug maker in $14 billion dealchief executive of Pfizer, said in the statement Monday. The deal is Pfizer’s
Pfizer to buy cancer drug maker in $14 billion deal
Boston Globe / Posted 7 days ago
chief executive of Pfizer, said in the statement Monday. The deal is Pfizer’s largest since its $152 billion merger with Allergan was terminated in April. That transaction had been structured as a so-called inversion, which meant that Pfizer... Read more
117 related stories
7d
CNBC
I'm not touching this stock until it cleans up & has a good quarterI'm going to send you to Federal Realty or Ventas." Synergy Pharmaceuticals: "
I'm not touching this stock until it cleans up & has a good quarter
CNBC / Posted 7 days ago
I'm going to send you to Federal Realty or Ventas." Synergy Pharmaceuticals: "I don't think that Brent Saunders [CEO of Allergan] is going to buy them ... Look, it's had a good run. It's almost doubled. I would say it's for speculation only.... Read more
7d
Zero Hedge
Congress Demand An Explanation For Epipen Price Increases; Mylan Slideswhich initially focused on Martin Shrekli's price hike of the Turing Pharmaceut
Congress Demand An Explanation For Epipen Price Increases; Mylan Slides
Zero Hedge / Posted 7 days ago
which initially focused on Martin Shrekli's price hike of the Turing Pharmaceuticals Daraprim drug, then shifted to Allergan (and everyone knows what happened after), over the past few days much of the media's attention has focused on the... Read more
14 related stories
7d
Fortune
Here's Why Pfizer's Medivation Deal Won't Solve Its Biggest Problembulking itself (acquiring Hospira last year), trying to move overseas (its coll
Here's Why Pfizer's Medivation Deal Won't Solve Its Biggest Problem
Fortune / Posted 7 days ago
bulking itself (acquiring Hospira last year), trying to move overseas (its collapsed $160 billion inversion deal with Allergan agn) and considering breaking itself up. Earlier this month, Pfizer’s CEO suggested that, actually, the company... Read more
117 related stories
7d
The Hindu
Pfizer to buy Medivation in $14-billion dealthe San Francisco-based company to put itself up for sale. The deal comes four
Pfizer to buy Medivation in $14-billion deal
The Hindu / Posted 7 days ago
the San Francisco-based company to put itself up for sale. The deal comes four months after Pfizer and Ireland-based Allergan Plc scrapped their $160 billion merger. Pfizer has since bought Anacor Pharmaceuticals Inc in a $5.2 billion deal to... Read more
117 related stories
7d
Business Wire
OTC Bulletin 2016: The Business Newsletter for the Consumer Healthcare IndustryLatin America - Key brands drive up turnover at Sanofi - BioGaia signs up Axe
OTC Bulletin 2016: The Business Newsletter for the Consumer Healthcare Industry
Business Wire / Posted 7 days ago
Latin America - Key brands drive up turnover at Sanofi - BioGaia signs up Axero as distributor in Sri Lanka - Pfizer and Allergan enter merger talks - Elder committed to paying off debts 2. General News - US adults trying new supplement... Read more
7d
The Economic Times
Pfizer buys Medivation for $14 bn to boost cancer drug rosterfor sale. The deal, which Pfizer said would immediately boost its earnings, co
Pfizer buys Medivation for $14 bn to boost cancer drug roster
The Economic Times / Posted 7 days ago
for sale. The deal, which Pfizer said would immediately boost its earnings, comes four months after it and Ireland-based Allergan Plc scrapped their $160 billion merger. Pfizer has since bought Anacor Pharmaceuticals Inc in a $5.2 billion deal to... Read more
117 related stories
7d
Channel NewsAsia
Pfizer to acquire Medivation for US$14bof about US$116 billion after a lengthy unsolicited courtship. Pfizer in April
Pfizer to acquire Medivation for US$14b
Channel NewsAsia / Posted 7 days ago
of about US$116 billion after a lengthy unsolicited courtship. Pfizer in April terminated a proposed US$160 billion merger with Allergan after the US Treasury set new rules designed to block cross-border deals that are structured to avoid US t... Read more
117 related stories
7d
Hawaii News Now
Pfizer spends $14B on Medivation in cancer fightfourth quarter. The Pfizer-Medivation deal is much smaller than Pfizer's propo
Pfizer spends $14B on Medivation in cancer fight
Hawaii News Now / Posted 7 days ago
fourth quarter. The Pfizer-Medivation deal is much smaller than Pfizer's proposed, $160-billion combination with Ireland's Allergan, a plan the drugmakers scrapped after the Treasury Department issued new rules this spring aimed specially at... Read more
117 related stories
7d
The Champaign News-Gazette
Pfizer buying Medivation in $14 billion deallargest. The Pfizer-Medivation deal also is much smaller than Pfizer's propose
Pfizer buying Medivation in $14 billion deal
The Champaign News-Gazette / Posted 7 days ago
largest. The Pfizer-Medivation deal also is much smaller than Pfizer's proposed, $160-billion combination with Ireland's Allergan, a plan the drugmakers scrapped after the Treasury Department issued new rules this spring aimed specially at... Read more
117 related stories
More

People in this news